tiprankstipranks
Shin Nippon Biomedical Laboratories, Ltd. (JP:2395)
:2395
Japanese Market
2395
Shin Nippon Biomedical Laboratories, Ltd.
RESEARCH TOOLSreports
Want to see JP:2395 full AI Analyst Report?

Shin Nippon Biomedical Laboratories, Ltd. (2395) Financial Statements

2 Followers

Shin Nippon Biomedical Laboratories, Ltd. Financial Overview

Shin Nippon Biomedical Laboratories, Ltd.'s market cap is currently ¥53.29B. The company's EPS TTM is ¥121.63; its P/E ratio is 6.41; and it has a dividend yield of 2.79%. Shin Nippon Biomedical Laboratories, Ltd. is scheduled to report earnings on May 11, 2026, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Mar 25Mar 24Mar 23Mar 22
Income Statement
Total Revenue¥ 32.52B¥ 32.41B¥ 26.45B¥ 25.09B¥ 17.75B
Gross Profit¥ 15.83B¥ 16.57B¥ 14.28B¥ 13.05B¥ 9.69B
Operating Income¥ 2.65B¥ 2.99B¥ 4.16B¥ 5.25B¥ 4.20B
EBITDA¥ 6.09B¥ 8.83B¥ 8.98B¥ 9.49B¥ 9.49B
Net Income¥ 4.57B¥ 4.92B¥ 5.53B¥ 6.06B¥ 7.13B
Balance Sheet
Cash & Short-Term Investments¥ 18.54B¥ 12.03B¥ 10.61B¥ 10.53B¥ 7.00B
Total Assets¥ 105.06B¥ 92.42B¥ 76.30B¥ 58.31B¥ 39.38B
Total Debt¥ 41.26B¥ 34.61B¥ 26.33B¥ 18.93B¥ 9.28B
Net Debt¥ 22.72B¥ 22.57B¥ 16.06B¥ 8.40B¥ 2.65B
Total Liabilities¥ 61.57B¥ 52.33B¥ 42.14B¥ 31.95B¥ 19.66B
Stockholders' Equity¥ 43.12B¥ 40.02B¥ 34.11B¥ 26.21B¥ 19.56B
Cash Flow
Free Cash Flow¥ 3.15B¥ -3.82B¥ -6.50B¥ -951.70M¥ 4.34B
Operating Cash Flow¥ 8.33B¥ 7.04B¥ 2.11B¥ 4.00B¥ 5.95B
Investing Cash Flow¥ -6.79B¥ -11.69B¥ -6.91B¥ -5.93B¥ -4.27B
Financing Cash Flow¥ 4.51B¥ 5.91B¥ 5.32B¥ 6.27B¥ -4.91B
Currency in JPY

Shin Nippon Biomedical Laboratories, Ltd. Earnings and Revenue History

Income Statement >

Shin Nippon Biomedical Laboratories, Ltd. Debt to Assets

Balance Sheet >

Shin Nippon Biomedical Laboratories, Ltd. Cash Flow

Cash Flow >

Shin Nippon Biomedical Laboratories, Ltd. Forecast EPS vs Actual EPS

Earnings >